Pure Monograph vs Certara CoAuthor
Both products apply AI to scientific writing, but they approach the problem from different angles. CoAuthor embeds inside Microsoft Word for medical writers. Pure Monograph is a web-first monograph engine that also covers trial analysis and pipeline intelligence.
Short answer. CoAuthor is an enterprise-focused, Word-plugin, human-in-the-loop writing assistant rebranded from Synchrogenix Writer in June 2024. Pure Monograph is enterprise pharmaceutical intelligence: asset intelligence, Trial Autopsy, Trial Counterfactual. Different form factor, different scope, partial overlap at the narrative layer.
At a glance
| Dimension | Pure Monograph | Certara CoAuthor |
|---|---|---|
| Primary deliverable | Source-traced monographs, trial analysis, intelligence briefs | Regulatory writing deliverables drafted and reviewed inside Word |
| Category | Molecule intelligence | Enterprise AI plugin for MS Word |
| Regulatory output | Cited reports exported as Word/PDF; not a submission publisher | Clinical and regulatory documents with human-in-the-loop reference checking |
| Workflow | Browser, no install; Word/PDF export | Microsoft Word plugin, integrates with Word track-changes and referencing |
| Pricing | Free: one named-molecule report. No upload. Enterprise: team workspace. | Enterprise licensing (Certara Nasdaq: CERT) |
| Engagement model | Self-serve report, then ask us for a team workspace | Enterprise sales + services partnership |
| Ownership | Burrard Pharmaceutical Enterprises Ltd., Vancouver BC | Certara (Nasdaq: CERT). CoAuthor rebranded from Synchrogenix Writer June 2024. |
Where CoAuthor wins
CoAuthor is built for enterprise medical writing teams that live in Word. Its human-in-the-loop model, reference management, and integration with Certara's broader Regulatory Writing practice are hard to beat for high-volume CSR and Module 2 authoring at large pharma.
Where Pure Monograph wins
Pure Monograph is stronger outside pure medical writing: assembling the public evidence for a molecule, taking a failed trial apart, modeling the trials that were never run, and competitive intelligence. Gaps stay marked.
Using both in sequence
A pragmatic pattern: assemble the scientific case in Pure Monograph, export to Word, hand off to the regulatory medical writing team using CoAuthor for final reference checking and style enforcement. Module 2 clinical summary work stays in CoAuthor end-to-end.
Frequently asked questions
What is Certara CoAuthor?
CoAuthor is Certara's AI-assisted regulatory writing product. It was rebranded from Synchrogenix Writer in June 2024 and runs as a human-in-the-loop plugin inside Microsoft Word, targeting regulatory medical writers at enterprise sponsors.
How is Pure Monograph different?
Pure Monograph is a web-first source-traced monograph engine. It does not install inside Word; it exports Word and PDF. It also covers trial analysis and intelligence surfaces CoAuthor does not.
Which fits enterprise regulatory medical writing teams?
Teams built around Word-centric workflows and high-volume medical writing typically adopt CoAuthor. Teams that need the scientific case assembled from public evidence lean toward Pure Monograph.
Can both be used together?
Yes. Assemble the case in Pure Monograph, export to Word, continue in CoAuthor with reference checking and style enforcement.